TENCENT
00700
BILIBILI-W
09626
TRIP.COM-S
09961
XIAOMI-W
01810
JD HEALTH
06618
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | 27.98%10.15B | 16.60%6.32B | -4.99%10.49B | --7.93B | --5.42B | 10.11%2.38B | 42.41%11.04B | --2.16B | -17.11%7.75B | --9.35B |
Profit adjustment | ||||||||||
Dividend (income)- adjustment | 85.65%-427K | 83.20%-426K | 82.35%-2.44M | ---2.98M | ---2.54M | ---- | 56.64%-13.81M | ---485K | -7.78%-31.85M | ---29.55M |
Attributable subsidiary (profit) loss | 14.14%50.38M | 364.04%62.58M | 990.05%67.19M | --44.14M | --13.49M | 128.88%12.57M | 82.30%-7.55M | ---43.52M | -295.52%-42.66M | --21.82M |
Impairment and provisions: | 972.59%271.67M | 351.86%161.18M | -83.96%152.82M | ---31.13M | ---64M | -82.25%6.07M | 49.04%952.86M | --34.2M | 25.90%639.34M | --507.81M |
-Impairmen of inventory (reversal) | -34.66%1.96M | -35.39%1.31M | 13.00%62.39M | --3.01M | --2.03M | -35.34%944K | 676.98%55.21M | --1.46M | --7.11M | ---- |
-Other impairments and provisions | 890.01%269.71M | 342.15%159.87M | -89.93%90.43M | ---34.14M | ---66.02M | -84.34%5.13M | 41.98%897.64M | --32.74M | 24.50%632.24M | --507.81M |
Revaluation surplus: | -3.41%-495.97M | -1.48%-294.67M | 19.88%-529.51M | ---479.62M | ---290.38M | -37.53%-183.59M | -19.37%-660.87M | ---133.49M | 3.60%-553.64M | ---574.3M |
-Other fair value changes | -3.41%-495.97M | -1.48%-294.67M | 19.88%-529.51M | ---479.62M | ---290.38M | -37.53%-183.59M | -19.37%-660.87M | ---133.49M | 3.60%-553.64M | ---574.3M |
Asset sale loss (gain): | 18.76%-160.03M | 1.09%-176.35M | 10.33%-235.75M | ---196.99M | ---178.3M | -151.12%-12.1M | 84.36%-262.92M | ---4.82M | -643.98%-1.68B | ---226.01M |
-Loss (gain) from sale of subsidiary company | 44.49%-148.19M | 43.53%-137.26M | 8.11%-289.65M | ---266.94M | ---243.04M | 349.69%809K | 83.21%-315.22M | ---324K | -323.18%-1.88B | ---443.63M |
-Loss (gain) on sale of property, machinery and equipment | -116.93%-11.85M | -160.39%-39.1M | 3.03%53.89M | --69.95M | --64.74M | -187.21%-12.91M | -73.29%52.31M | ---4.5M | -10.00%195.84M | --217.61M |
Depreciation and amortization: | 0.97%12.97B | 3.53%8.77B | 6.60%17.27B | --12.85B | --8.47B | 5.81%4.2B | 28.42%16.2B | --3.97B | 24.29%12.62B | --10.15B |
-Depreciation | 5.87%7.86B | 11.41%5.36B | 12.92%10.11B | --7.42B | --4.81B | ---- | 30.12%8.95B | ---- | --6.88B | ---- |
-Other depreciation and amortization | 14.31%-30.35M | 25.80%-20.42M | -22.77%-45.94M | ---35.41M | ---27.52M | 32.13%-7.16M | -2.56%-37.42M | ---10.55M | 7.10%-36.48M | ---39.27M |
Financial expense | 7.25%1.8B | 12.65%1.23B | 10.48%2.27B | --1.68B | --1.09B | 5.29%541.07M | 31.44%2.05B | --513.89M | 11.12%1.56B | --1.41B |
Exchange Loss (gain) | ---- | ---- | ---- | ---- | ---- | 33.85%126.03M | ---- | --94.16M | ---- | ---23.66M |
Special items | -56.44%83.83M | -54.42%69.94M | 182.31%309.34M | --192.45M | --153.46M | 116.55%77.91M | -68.63%109.57M | --35.98M | 23.25%349.31M | --283.42M |
Operating profit before the change of operating capital | 12.23%24.68B | 10.45%16.14B | 1.28%29.79B | --21.99B | --14.62B | 7.86%7.15B | 42.71%29.41B | --6.63B | -1.23%20.61B | --20.87B |
Change of operating capital | ||||||||||
Inventory (increase) decrease | 132.34%70.61M | -35.62%-119.28M | -23.70%-491.31M | ---218.31M | ---87.95M | 710.23%67.02M | -7.18%-397.19M | ---10.98M | -235.28%-370.58M | ---110.53M |
Accounts receivable (increase)decrease | -53.07%1.05B | -76.01%896.44M | -102.98%-262.5M | --2.23B | --3.74B | ---- | 242.30%8.82B | ---- | ---6.2B | ---- |
Accounts payable increase (decrease) | -34.51%-1.07B | 32.67%-1.71B | 1,554.31%759M | ---792.61M | ---2.53B | -243.48%-2.15B | -101.14%-52.19M | ---624.79M | 324.96%4.59B | ---2.04B |
Cash from business operations | 6.56%24.73B | -3.29%15.21B | -21.13%29.8B | --23.2B | --15.73B | -15.38%5.07B | 102.77%37.78B | --5.99B | -0.46%18.63B | --18.72B |
Other taxs | 2.43%-2.17B | 21.76%-1.49B | 36.46%-3.23B | ---2.23B | ---1.91B | 35.37%-766.89M | -98.86%-5.08B | ---1.19B | 7.21%-2.55B | ---2.75B |
Net cash from operations | 7.51%22.55B | -0.74%13.72B | -18.75%26.57B | --20.98B | --13.82B | -10.44%4.31B | 103.39%32.7B | --4.81B | 0.70%16.08B | --15.97B |
Cash flow from investment activities | ||||||||||
Dividend received - investment | -4.93%598.66M | -10.65%387.34M | -12.54%798.63M | --629.73M | --433.49M | 23.35%166.65M | 86.19%913.1M | --135.11M | -3.20%490.4M | --506.63M |
Sale of fixed assets | 22.58%237.26M | 49.71%179.38M | 90.45%335.83M | --193.56M | --119.82M | 62.62%94.79M | 19.63%176.33M | --58.29M | 127.04%147.4M | --64.92M |
Purchase of fixed assets | 19.09%-6.85B | 6.95%-5.08B | 12.07%-12.47B | ---8.47B | ---5.45B | 16.97%-2.93B | 26.11%-14.18B | ---3.53B | -56.48%-19.2B | ---12.27B |
Sale of subsidiaries | -20.11%535.83M | 36.98%495.3M | -26.22%852.37M | --670.71M | --361.59M | -98.57%4.71M | -51.09%1.16B | --328.65M | 3,832.68%2.36B | --60.06M |
Acquisition of subsidiaries | 38.19%-662.71M | 33.45%-628.53M | 29.13%-2.37B | ---1.07B | ---944.49M | -27.83%-98.8M | 64.39%-3.34B | ---77.29M | -1,034.03%-9.38B | ---826.97M |
Recovery of cash from investments | -22.23%54.91B | -42.20%28.39B | -39.83%93.6B | --70.6B | --49.12B | -35.68%23.01B | 34.84%155.56B | --35.78B | 2.81%115.37B | --112.21B |
Cash on investment | 9.85%-72.63B | 31.01%-39.51B | 38.14%-94.25B | ---80.56B | ---57.27B | 20.60%-34.41B | -28.85%-152.37B | ---43.34B | -2.66%-118.26B | ---115.19B |
Other items in the investment business | --316.66M | --316.66M | ---- | ---- | ---- | ---- | ---- | ---- | 1,954.89%11.33B | --551.5M |
Net cash from investment operations | -30.78%-23.55B | -13.28%-15.44B | -11.70%-13.51B | ---18B | ---13.63B | -33.09%-14.16B | 29.42%-12.09B | ---10.64B | -15.10%-17.13B | ---14.88B |
Net cash before financing | -133.41%-993.27M | -1,000.60%-1.72B | -36.62%13.06B | --2.97B | --191.24M | -68.97%-9.86B | 2,058.76%20.61B | ---5.83B | -197.19%-1.05B | --1.08B |
Cash flow from financing activities | ||||||||||
New borrowing | -5.31%26.39B | 25.40%19.58B | 17.70%32.59B | --27.87B | --15.62B | 3.71%9.69B | -11.84%27.69B | --9.35B | 184.78%31.41B | --11.03B |
Refund | -100.42%-32.48B | -47.81%-15.68B | 26.35%-23.3B | ---16.21B | ---10.61B | 65.49%-4.98B | -29.37%-31.63B | ---14.42B | -81.35%-24.45B | ---13.48B |
Issuance of bonds | 186.53%4.3B | 119.91%3.3B | -87.38%1.5B | --1.5B | --1.5B | -74.50%1.5B | -9.05%11.88B | --5.88B | 46.33%13.06B | --8.93B |
Interest paid - financing | -3.50%-1.34B | -11.84%-952.57M | -25.36%-1.82B | ---1.29B | ---851.71M | -55.12%-417.33M | -74.30%-1.45B | ---269.03M | -14.26%-832.98M | ---729M |
Dividends paid - financing | -81.18%-3.17B | -92.03%-3.07B | 18.93%-1.81B | ---1.75B | ---1.6B | 92.55%-5.81M | 81.92%-2.24B | ---78.01M | -940.61%-12.37B | ---1.19B |
Absorb investment income | -76.30%32.93M | -50.84%27.97M | -3.44%157.08M | --138.95M | --56.89M | -61.28%32.44M | -99.32%162.67M | --83.78M | 3,364.87%23.79B | --686.75M |
Issuance expenses and redemption of securities expenses | 69.39%-2.93B | 53.84%-2.34B | -27.24%-11.07B | ---9.57B | ---5.06B | -32.93%-3.04B | -210.73%-8.7B | ---2.29B | 27.92%-2.8B | ---3.88B |
Other items of the financing business | -141.12%-3.37B | -2,550.65%-3.35B | 62.30%-1.47B | ---1.4B | ---126.29M | 99.70%-1.46M | -1,914.24%-3.91B | ---485.57M | -624.71%-194.09M | ---26.78M |
Net cash from financing operations | -180.15%-18.16B | -24.54%-6.18B | 18.87%-12.99B | ---6.48B | ---4.96B | 120.70%839.99M | -178.14%-16.02B | ---4.06B | 719.03%20.5B | ---3.31B |
Effect of rate | -72.06%2.83M | -122.17%-28.17M | -88.66%98.84M | --10.12M | --127.05M | -61.84%-126.51M | 980.27%871.64M | ---78.17M | -43.03%-99.02M | ---69.23M |
Net Cash | -445.62%-19.16B | -65.62%-7.9B | -98.49%69.52M | ---3.51B | ---4.77B | 8.85%-9.02B | -76.37%4.59B | ---9.89B | 972.53%19.45B | ---2.23B |
Begining period cash | 0.42%40.45B | 0.42%40.45B | 15.70%40.28B | --40.28B | --40.28B | 15.70%40.28B | 125.09%34.81B | --34.81B | -12.94%15.47B | --17.76B |
Cash at the end | -42.10%21.29B | -8.75%32.52B | 0.42%40.45B | --36.78B | --35.63B | 25.33%31.14B | 15.70%40.28B | --24.84B | 125.09%34.81B | --15.47B |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | -- | PricewaterhouseCoopers | -- | -- | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.